Fingerprint
Dive into the research topics of 'Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin)
Seung Tae Kim, Soomin Ahn, Jeeyun Lee, Su Jin Lee, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Kyoung Mee Kim, Joon Oh Park
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations